Collegium Pharmaceutical, Inc. - Laporan Laba Rugi (TTM)

Collegium Pharmaceutical, Inc.
US ˙ NasdaqGS ˙ US19459J1043

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Collegium Pharmaceutical, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 308 310 321 326 326 277 273 314 362 464 525 537 547 567 567 577 599 631 664 707
Change (%) 0.67 3.62 1.52 -0.10 -15.01 -1.43 14.88 15.36 28.27 13.15 2.29 1.81 3.68 0.03 1.72 3.92 5.37 5.20 6.43
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 100 70 58 61 62 59 59 65 69 118 83 81 81 80 79 79 80 84 86 88
Change (%) -30.30 -17.12 5.22 2.88 -5.27 0.68 8.64 6.45 71.84 -30.11 -1.86 -0.27 -1.39 -0.98 0.56 0.66 4.53 3.03 2.60
% of Revenue 32.38 22.42 17.93 18.59 19.14 21.34 21.79 20.61 19.02 25.48 15.74 15.10 14.79 14.07 13.92 13.77 13.34 13.23 12.96 12.49
Gross Operating Profit 208 241 264 266 263 218 213 249 293 346 442 456 466 487 488 497 519 548 578 619
Change (%) 15.50 9.61 0.71 -0.78 -17.32 -2.01 16.62 17.68 18.04 27.94 3.06 2.18 4.56 0.19 1.90 4.44 5.50 5.53 7.00
% of Revenue 67.62 77.58 82.07 81.41 80.86 78.66 78.21 79.39 80.98 74.52 84.26 84.90 85.21 85.93 86.08 86.23 86.66 86.77 87.04 87.51
SG&A 112 114 114 115 119 119 113 119 127 172 158 159 156 151 148 151 157 183 217 247
Change (%) 1.55 0.19 0.92 3.55 -0.19 -5.37 5.90 6.20 36.00 -8.34 0.75 -1.64 -3.64 -1.52 1.41 4.50 16.34 18.82 13.67
% of Revenue 36.40 36.72 35.50 35.29 36.58 42.97 41.25 38.03 35.01 37.11 30.07 29.62 28.61 26.59 26.18 26.10 26.25 28.98 32.73 34.96
R&D 10 10 10 11 10 9 11 7 6 4 0 0 0
Change (%) 0.76 2.70 9.66 -6.28 -8.37 11.14 -32.96 -20.59 -28.77 -100.00 NaN NaN
% of Revenue 3.15 3.15 3.12 3.37 3.17 3.41 3.85 2.25 1.55 0.86 0.00 0.00 0.00
OpEx 269 254 249 254 259 255 252 281 312 426 390 390 386 376 370 370 382 432 490 543
Change (%) -5.69 -1.94 2.02 2.03 -1.69 -1.10 11.52 10.99 36.59 -8.31 -0.10 -1.04 -2.54 -1.60 -0.11 3.19 13.18 13.42 10.81
% of Revenue 87.38 81.86 77.47 77.85 79.51 91.98 92.29 89.59 86.20 91.79 74.38 72.64 70.61 66.37 65.29 64.12 63.67 68.39 73.73 76.76
Operating Income 39 56 72 72 67 22 21 33 50 38 134 147 161 191 197 207 218 200 175 164
Change (%) 44.69 28.69 -0.19 -7.58 -66.73 -5.26 55.07 53.03 -23.67 252.97 9.21 9.37 18.63 3.24 5.15 5.23 -8.30 -12.57 -5.84
% of Revenue 12.62 18.14 22.53 22.15 20.49 8.02 7.71 10.41 13.80 8.21 25.62 27.36 29.39 33.63 34.71 35.88 36.33 31.61 26.27 23.24
Interest Expense -21 -29 -30 -27 -24 -21 -21 -33 -47 -63 -79 -83 -85 -83 -79 -73 -71 -74 -77 -82
Change (%) 35.24 3.11 -9.53 -10.94 -12.42 0.52 58.42 41.63 33.37 24.67 5.20 2.08 -1.53 -4.91 -7.92 -3.25 4.78 4.67 6.30
% of Revenue -6.93 -9.32 -9.27 -8.26 -7.37 -7.59 -7.74 -10.67 -13.10 -13.63 -15.01 -15.44 -15.48 -14.70 -13.98 -12.65 -11.78 -11.71 -11.66 -11.64
Net Income 18 27 42 107 104 72 43 -35 -43 -25 -29 -11 9 48 93 100 89 69 44 36
Change (%) 52.06 56.86 154.38 -3.04 -30.91 -40.17 -182.38 21.53 -41.63 17.43 -61.98 -180.78 434.11 93.74 7.07 -11.31 -21.90 -36.56 -17.37
% of Revenue 5.71 8.63 13.06 32.73 31.77 25.83 15.68 -11.24 -11.84 -5.39 -5.59 -2.08 1.65 8.50 16.46 17.32 14.78 10.96 6.61 5.13

Source: Capital IQ

Other Listings
DE:354 € 33.40
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista